NoduleRisk vs PE Classifier
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
NoduleRisk
Read full descriptionHide full description
NoduleRisk is a clinical decision support tool for physicians evaluating pulmonary nodule malignancy risk. It computes probability estimates and management guidance across five validated models simultaneously. MODELS INCLUDED • Mayo Clinic (ACCP) — logistic regression model for incidentally detected nodules • Brock (BTS/PanCan) — recommended for screening populations; validated in the Pan-Canadian Lung Cancer Screening Study • Herder (BTS) — incorporates FDG-PET/CT uptake when available • BIMC (Bayesian) — Bayesian likelihood ratio model with adjustable prior probability; displays individual likelihood ratio contributions • Fleischner 2017 — guideline-based follow-up recommendations with automatic risk stratification FEATURES • Multi-nodule evaluation (up to 6 nodules per patient) • Volume doubling time calculation from serial CT measurements • Risk-stratified management recommendations for each model • Applicability warnings when inputs are outside model validation ranges • Clinical context adjustments for screening and biopsy-referred populations • Fully offline — no data is transmitted or stored IMPORTANT NoduleRisk is intended for use by qualified clinicians as a decision support aid only. Results must be interpreted in the context of the full clinical picture and do not substitute for institutional guidelines, multidisciplinary team discussion, or clinical judgment.
PE Classifier
This educational reference tool helps medical professionals and students understand and apply the latest acute pulmonary embolism classification system. It features interactive diagrams, a built-in checklist, and direct links to source guidelines for comprehensive learning.
- Full Category A-E classification with sub-stages
- Interactive visual diagrams
- Built-in HESTIA checklist
- Optional local case log
- Direct link to source guideline
Read full descriptionHide full description
PEClassifier is an educational reference tool designed to help medical students, residents, and clinical trainees learn and apply the 2026 AHA/ACC/ACCP/ACEP/CHEST acute pulmonary embolism classification system. LEARN THE FRAMEWORK The 2026 guideline introduced a comprehensive Category A–E classification system for acute PE severity. PEClassifier walks you through every category and sub-stage — B1/B2, C1–C3, D1–D2, and E1–E2 — with interactive diagrams that show how clinical criteria map to each classification. Understand not just the answer, but the reasoning behind it. Utilizes validated 11-item HESTIA checklist used to evaluate outpatient management eligibility — a key concept tested on boards and applied throughout clinical training. FEATURES - Full Category A–E classification with all sub-stages and R respiratory modifier - Interactive visual diagrams for every classification category - Built-in HESTIA checklist with all 11 validated criteria - Optional case log for self-study and review — saved locally on your device only, never transmitted anywhere - Direct link to the 2026 source guideline for reference and citation PRIVACY PEClassifier does not collect, transmit, or store any personally identifiable information. Any case log entries you save are stored locally on your device only, are entirely non-identifying, and are never shared with or sold to any third party. Uninstalling the app permanently removes all saved data. WHO IT'S FOR PEClassifier is intended for licensed healthcare professionals, medical students, and clinical trainees. It is not directed at children and is designed exclusively for educational and professional reference use. DISCLAIMER PEClassifier is an educational and reference tool. It is not a diagnostic device and is not intended to replace clinical judgment, established diagnostic protocols, or consultation with a qualified healthcare provider. A disclaimer is displayed within the app on a recurring basis to reinforce this.
Screenshots
Verdict
The clearest difference is device support: PE Classifier at 3 against NoduleRisk's 1. PE Classifier also leads on iOS requirement (15.1 vs 17.6). On price, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
| Parameter | NoduleRisk | PE Classifier |
|---|---|---|
| Price | Free | Free |
| Rating | — | 5.0 (1 ratings) — better |
| Number of ratings | — | 1 — better |
| Update frequency | — | Monthly |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | — | Free |
| Devices | iPhone | iPhone, iPad, iPod — better |
| Requires iOS | 17.6 | 15.1 — better |
| Further details — not scored | ||
| Size | 2 MB | 24 MB |
| Age rating | 17+ | 17+ |
| Developer | Rutvik Shah | Dawwod George |
In-app purchases
NoduleRisk
No in-app purchases
PE Classifier
No in-app purchases









